MiR-155-5p Promotes Dorsal Root Ganglion Neuron Axonal Growth in an Inhibitory Microenvironment Via the CAMP/PKA Pathway
Overview
Authors
Affiliations
Sensory dysfunction post spinal cord injury causes patients great distress. Sciatic nerve conditioning injury (SNCI) has been shown to restore sensory function after spinal cord dorsal column injury (SDCL); however, the underlying mechanism of this recovery remains unclear. We performed a microarray assay to determine the associated miRNAs that might regulate the process of SNCI promoting SDCL repair. In total, 13 miRNAs were identified according to our inclusion criteria, and RT-qPCR was used to verify the microarray results. Among the 13 miRNAs, the miR-155-5p levels were decreased at 9 h, 3 d, 7 d, 14 d, 28 d, 2 m and 3 m timepoints in the SDCL group, while the SNCI group had a smaller decrease. Thus, miR-155-5p was chosen for further study after a literature review and an analysis with the TargetScan online tool. Specifically, miR-155-5p targets PKI-α, and the expression pattern of PKI-α was opposite that of miR-155-5p in both the SDCL and SNCI groups. Interestingly, miR-155-5p could promote dorsal root ganglion (DRG) neuron axon growth via the cAMP/PKA pathway and in a TNF-α, IL-1β or MAG inhibitory microenvironment in vitro. Furthermore, miR-155-5p could regulate the cAMP/PKA pathway and promote sensory conduction function recovery post dorsal column injury as detected by NF-200 immunohistochemistry, somatosensory-evoked potentials, BBB scale and tape removal test. Collectively, our results demonstrated that miR-155-5p participates in the molecular mechanism by which SNCI promotes the repair of SDCL and that upregulated miR-155-5p can repair SDCL by enhancing DRG neuron axon growth via the cAMP/PKA pathway. These findings suggest a novel treatment target for spinal cord injury.
Role and Interplay of Different Signaling Pathways Involved in Sciatic Nerve Regeneration.
Zare Jalise S, Habibi S, Fath-Bayati L, Habibi M, Ababzadeh S, Hosseinzadeh F J Mol Neurosci. 2024; 74(4):108.
PMID: 39531101 DOI: 10.1007/s12031-024-02286-4.
Chen T, Wan L, Xiao Y, Wang K, Wu P, Li C J Nanobiotechnology. 2024; 22(1):653.
PMID: 39443923 PMC: 11515499. DOI: 10.1186/s12951-024-02916-4.
Cazzanelli P, Lamoca M, Hasler J, Hausmann O, Mesfin A, Puvanesarajah V Cell Commun Signal. 2024; 22(1):419.
PMID: 39192354 PMC: 11351051. DOI: 10.1186/s12964-024-01803-7.
Wang X, Li W, Zhang J, Li J, Zhang X, Wang M J Transl Med. 2023; 21(1):511.
PMID: 37507810 PMC: 10385911. DOI: 10.1186/s12967-023-04375-1.
Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer's disease.
Liu J, Long Y, Xu P, Guo H, Cui G Alzheimers Res Ther. 2023; 15(1):122.
PMID: 37452431 PMC: 10347850. DOI: 10.1186/s13195-023-01264-z.